Table 1 Possible benefits for stakeholders in Member States
Decision-makers | Researchers |
- Quality information for evidence-based decisions - Better preparedness - International comparison: evaluate and discuss how to tackle similar challenges - Programme evaluation - Priority setting - Organise and coordinate public health expertise and systems - Better access to existing knowledge and expertise | - EU-comparative data - Data quality - Continuous availability - Enhanced research capacity and international collaboration - Larger study populations and cohorts - Enhanced data access flow - Structured scientific exchange - Quicker results - Better access to existing knowledge and expertise |
Healthcare providers | Citizens |
- Data to set standards and protocols for evidence-based care and to evaluate their policies - Benchmarking i.e. learning from best practices - Better access to existing knowledge and expertise | - Improved health and wellbeing by enhanced monitoring of health risks, health status, health determinants, and the safety and quality of healthcare services - Patient reported outcomes and experiences (PROMS and PREMS) - Reduced health inequalities: promoting equitable distribution of health and wellbeing - Better access to existing knowledge and expertise |
Administrators/data providers | Financers |
- Reduce burden by increasing harmonisation of international data collection to reduce duplication - Assist in obligation to provide data to international sources | - Better value for money in international health information activities and health research - Optimise funds allocation |